Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

This company is a leader in two major areas, and these businesses are generating billion-dollar revenue. The stock looks very reasonably priced today, offering room to run. 10 stocks we like better ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, ...

Lumen is deep into a huge turnaround effort, and investors are starting to see progress. The company must continue to reduce its debt burden to fully right itself. New partnerships and improving ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

These two overlooked Canadian stocks show how patient investors can still find undervalued stocks even after a solid market ...

Bristol-Myers Squibb Company is rated a Buy with solid rebound and robust free cash flow margins. Learn more about BMY stock ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The new additions reflect Buffett’s value-investing ...

As the market continues to inch higher from a tech-led rally, dividend stocks lagged again. However, this provides long-term investors an opportunity to buy undervalued dividend-paying stocks at a ...

Artificial intelligence (AI) companies have been soaring in recent years -- so you wouldn't necessarily think that these players could be undervalued. But some, even high-quality companies that have ...